Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Other Revenue	3.43	3.92	5.12	4.34	-	4.95
Revenue	3.43	3.92	5.12	4.34	-	4.95
Revenue Growth (YoY)	-33.38%	-23.56%	18.06%	-	-	58.40%
Cost of Revenue	0.22	0.29	0.36	0.36	0.35	0.32
Gross Profit	3.21	3.63	4.76	3.98	-0.35	4.63
Selling, General & Admin	4.28	5.04	5.51	6.87	3.43	4.31
Research & Development	11.8	13.2	14.75	12.28	10.1	12.98
Other Operating Expenses	0.01	0.03	0	0	0.04	0.13
Operating Expenses	16.08	18.27	20.26	19.16	13.58	17.42
Operating Income	-12.87	-14.64	-15.5	-15.18	-13.93	-12.8
Interest & Investment Income	0.12	0.02	0	0.02	0.02	0.11
Currency Exchange Gain (Loss)	0.46	0.92	2.72	-0.3	0.33	0.35
EBT Excluding Unusual Items	-12.28	-13.7	-12.78	-15.45	-13.58	-12.34
Other Unusual Items	-	-	-	0.15	0.12	-
Pretax Income	-12.28	-13.7	-12.78	-15.31	-13.46	-12.34
Income Tax Expense	0	0.1	0.07	-	-	-
Net Income	-12.28	-13.81	-12.85	-15.31	-13.46	-12.34
Net Income to Common	-12.28	-13.81	-12.85	-15.31	-13.46	-12.34
Shares Outstanding (Basic)	2,473	2,428	2,406	1,697	895	616
Shares Outstanding (Diluted)	2,473	2,428	2,406	1,697	895	616
Shares Change (YoY)	2.65%	0.91%	41.79%	89.62%	45.33%	15.34%
EPS (Basic)	-0.00	-0.01	-0.01	-0.01	-0.02	-0.02
EPS (Diluted)	-0.00	-0.01	-0.01	-0.01	-0.02	-0.02
Free Cash Flow	-14.61	-20.04	-12.43	-17.34	-9.45	-13.96
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.01	-0.02
Gross Margin	93.53%	92.72%	92.88%	91.70%	-	93.49%
Operating Margin	-375.05%	-373.72%	-302.56%	-349.77%	-	-258.43%
Profit Margin	-	-	-250.75%	-	-	-249.19%
Free Cash Flow Margin	-425.92%	-511.78%	-242.54%	-399.59%	-	-281.99%
EBITDA	-12.83	-14.6	-15.48	-15.16	-13.9	-12.77
EBITDA Margin	-	-	-	-	-	-257.83%
D&A For EBITDA	0.04	0.04	0.02	0.02	0.03	0.03
EBIT	-12.87	-14.64	-15.5	-15.18	-13.93	-12.8
EBIT Margin	-	-	-	-	-	-258.43%

Source: S&P Capital IQ. Standard template.